Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 172 participants.
Also called NCT02540018
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 172 participants
- Registry
-
NCT02540018
-
- Other papers using this trial's data
- Efficacy and safety of a novel paclitaxel-nano-coated balloon for femoropopliteal angioplasty: one-year results of the EffPac trial
- Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT02540018. Randomized; single masking; primary purpose treatment. Start 2015-09-15 (actual); primary completion 2016-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis
- Acronym
- EffPac
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- Transluminal Angioplasty with Paclitaxel-coated Luminor® Balloon Catheter in the Superficial Femoral and Popliteal Arteries
- Intervention (Device)
- Transluminal Angioplasty with and non-coated (CE-marked) plain old angioplasty balloon (POBA) catheter
- Lead sponsor
- Jena University Hospital
- Collaborator
- iVascular S.L.U.
- Collaborator
- KKS Netzwerk
Record details
- Record id
cardio:ct-nct02540018- Content hash
e7c6ff1e7a6fcfe34e1ea06123c0a4fd26bd7c0dc59f8d82b040fb413a75a4de